Attorneys general bring another ‘collusion’ case against generic makers, naming Novartis and Pfizer among over a dozen others
For the third time in the last four years, a coalition of attorneys general have filed an antitrust lawsuit against some of the world’s largest generic drugmakers, including Pfizer, Mylan and Novartis’ Sandoz unit, alleging that for years the companies fixed prices and manipulated the market for over 80 drugs.
The suit, brought by 51 attorneys general — including those of DC and every state besides California, Utah, South Dakota and Wyoming — is the latest bramble in a legal thicket that has ensnared the generics industry since 2016, when 20 state attorneys general accused Teva Pharmaceuticals and Mylan for an antibiotic and a diabetes drug. “We believe that this is just the tip of the iceberg,” then-Connecticut Attorney General George Jepsen said at the time.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.